PD6-1-7: A phase II study of UCN-01 in combination with topotecan in patients (pts) with chemosensitive relapsed small cell lung cancer (SCLC): a study of the Princess Margaret Hospital phase II consortium (PMH-C). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Leighl, Natasha
  • Laurie, Scott
  • Gauthier, Isabelle
  • Ellis, Peter
  • Duguay, Yannick
  • Pond, Gregory
  • Bhagwat, Manasi
  • Dancey, Janet
  • Moore, Malcolm
  • Goss, Glenwood

publication date

  • August 2007